Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allogenic recognition in 1992.

O Lantz1, P Alard, B Charpentier

  • 1Laboratoire d'Immunologie Cellulaire et de Transplantation, ER 424 CNRS, Villejuif, France.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 epidemic phases: Criteria, challenges and issues for the future.

Bulletin de l'Academie nationale de medecine·2020
Same author

[Covid-19 epidemic phases: Criteria, challenges and issues for the future].

Bulletin de l'Academie nationale de medecine·2020
Same author

Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials.

Transplantation proceedings·2017
Same author

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Pre-transplant donor CD4<sup>-</sup> invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Leukemia·2016
Same journal

Wnt activation during epileptogenesis prevents pathological immature dentate granule cell morphological changes in animal models of unilateral and bilateral temporal lobe epilepsy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Protective effects of ACF210, a dual GLP-1/APJ receptor agonist, against cardiovascular-kidney-metabolic syndrome induced by T2D.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum to "Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization" [Biomed. Pharmacother. 141 (2021) 111883].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
See all related articles

Recent advances reveal major histocompatibility complex (MHC) molecule structure and function, particularly peptide binding selectivity and T cell selection. Alloreactivity is primarily driven by housekeeping gene peptides on allogeneic MHC molecules.

Area of Science:

  • Immunology
  • Molecular Biology
  • Structural Biology

Background:

  • Significant new data on major histocompatibility complex (MHC) molecules have emerged in the past four years.
  • Understanding MHC structure and function is crucial for T cell interactions and immune responses.

Purpose of the Study:

  • To summarize recent structural data of MHC molecules.
  • To describe MHC functions in peptide presentation to T cells.
  • To discuss the selectivity of peptide binding to MHC molecules.

Main Methods:

  • Review and synthesis of recent structural and functional data on MHC molecules.
  • Analysis of T cell selection processes in the thymus (negative and positive selection).
  • Definition and categorization of alloreactivity types.

Related Experiment Videos

Main Results:

  • High selectivity observed in peptide binding to MHC molecules.
  • T cell repertoire is shaped by thymic selection.
  • Four types of alloreactivity are defined, with type 1 (housekeeping gene peptides on allogeneic MHC) being the predominant response.
  • Type 4 alloreactivity (allogeneic peptides on autologous MHC) role in rejection is under investigation.

Conclusions:

  • New data enhance understanding of H2 restriction and alloreactivity.
  • The primary driver of alloreactivity is the binding of housekeeping gene peptides to allogeneic MHC molecules.
  • Further research is needed to elucidate the role of type 4 alloreactivity in graft rejection.